Sodium-glucose cotransporter-2 inhibitors had a significant association with less atrial fibrillation

被引：0
|
作者：
Xiao, Yu [1 ]
Liu, Chao [1 ]
机构：
[1] Peoples Hosp Longhua, Dept Dermatol, Shenzhen 518109, Guangdong, Peoples R China
来源：
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY | 2024年 / 31卷 / 07期
关键词：
D O I：
10.1093/eurjpc/zwad408
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：e53 / e54
页数：2
相关论文
共 50 条
  • [1] Association of Sodium-Glucose Cotransporter-2 Inhibitors With Incident Atrial Fibrillation in Older Adults With Type 2 Diabetes
    Zhuo, Min
    D'Andrea, Elvira
    Paik, Julie M.
    Wexler, Deborah J.
    Everett, Brendan M.
    Glynn, Robert J.
    Kim, Seoyoung C.
    Patorno, Elisabetta
    JAMA NETWORK OPEN, 2022, 5 (10) : E2235995
  • [2] Sodium-glucose cotransporter-2 inhibitors protect against atrial fibrillation in patients with heart failure
    Zhou, Lili
    Yang, Yuanyuan
    Han, Weixing
    ANNALS OF PALLIATIVE MEDICINE, 2021, 10 (10) : 10887 - 10895
  • [3] IMPACT OF SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITORS ON RECURRENCE OF ATRIAL FIBRILLATION AFTER CATHETER ABLATION
    Abu-Qaoud, Moh'D Rasheed
    Kumar, Ashish
    Tarun, Tushar
    Ahmad, Javaria
    Kulbak, Guy
    Januzzi, James L., Jr.
    Neilan, Tomas G.
    Baron, Suzanne
    Martin, David T.
    Nohria, Anju
    Reynolds, Matthew R.
    Kosiborod, Mikhail
    Dani, Sourbha S.
    Ganatra, Sarju
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 37 - 37
  • [4] Sodium-Glucose Cotransporter-2 Inhibitors in Depression
    Liebers, David T.
    Ebina, Wataru
    Iosifescu, Dan V.
    HARVARD REVIEW OF PSYCHIATRY, 2023, 31 (04) : 214 - 221
  • [5] Gout and sodium-glucose cotransporter-2 inhibitors
    Lai, Shih-Wei
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 (01) : 112 - 113
  • [6] A New Hope: Sodium-Glucose Cotransporter-2 Inhibition to Prevent Atrial Fibrillation
    Karamichalakis, Nikolaos
    Kolovos, Vasileios
    Paraskevaidis, Ioannis
    Tsougos, Elias
    JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE, 2022, 9 (08)
  • [7] Sodium-Glucose Cotransporter-2 Inhibitors and the Risk of Incident Atrial Fibrillation in Older Adults with Type 2 Diabetes
    Zhuo, Min
    Paik, Julie M.
    Wexler, Deborah J.
    Everett, Brendan M.
    D'Andrea, Elvira
    Glynn, Robert
    Kim, Seoyoung C.
    Patorno, Elisabetta
    DIABETES, 2022, 71
  • [8] Association between sodium-glucose cotransporter-2 inhibitors and arrhythmic outcomes in patients with diabetes and pre-existing atrial fibrillation
    Fichadiya, Akash
    Quinn, Amity
    Au, Flora
    Campbell, Dennis
    Lau, Darren
    Ronksley, Paul
    Beall, Reed
    Campbell, David J. T.
    Wilton, Stephen B.
    Chew, Derek S.
    EUROPACE, 2024, 26 (03):
  • [9] The Impact of Sodium-Glucose Cotransporter-2 Inhibitors on Atrial Electromechanical Conduction Time
    Celik, Enes
    Kerkutluoglu, Murat
    Sahin, Murat
    Aksu, Ekrem
    Balcioglu, Akif Serhat
    TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, 2024, 52 (04): : 237 - 243
  • [10] Effects of Sodium-Glucose Cotransporter-2 Inhibitors on the Risk of Atrial Fibrillation in Older Adults with Type 2 Diabetes
    Li, Yujia
    Guo, Yi
    Kimmel, Stephen
    Bian, Jiang
    Schatz, Desmond
    Guo, Jingchuan
    DIABETES, 2023, 72
12345